FX Shoulder USA
Private Company
Funding information not available
Overview
FX Shoulder USA is a private, commercial-stage medical device company headquartered in Austin, Texas, specializing in shoulder replacement implants and systems. Founded in 2026, the company is building its presence in the orthopedic market through a comprehensive portfolio of shoulder arthroplasty solutions aimed at degenerative diseases and trauma. Its strategy heavily relies on surgeon education, hands-on training courses, and participation in major global orthopedic conferences to drive adoption. The company appears to be in an early commercial and market-building phase, with a primary focus on the US and European markets.
Technology Platform
Portfolio of artificial shoulder prosthesis systems for anatomic and reverse shoulder arthroplasty, including implants and surgical instrumentation for degenerative and trauma indications.
Opportunities
Risk Factors
Competitive Landscape
The shoulder arthroplasty market is dominated by large, diversified medical device companies like Zimmer Biomet, Stryker, Johnson & Johnson (DePuy Synthes), and Smith & Nephew. These competitors have broad product portfolios, extensive clinical data, and deep relationships with hospitals and surgeons. FX Shoulder must differentiate through product design, surgeon training, and potentially pricing to establish a foothold.